文献
J-GLOBAL ID:201802254726525241
整理番号:18A1190040
膵臓癌細胞におけるゲムシタビン取り込みに対する平衡ヌクレオシド輸送体1および2の寄与【JST・京大機械翻訳】
Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells
著者 (18件):
Hioki Masato
(Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan)
,
Hioki Masato
(Department of Pharmacy, Local Independent Administrative Institution Mie Prefectural General Medical Center, 5450-132 Hinaga, Yokkaichi City, Mie, 510-8561, Japan)
,
Shimada Takuya
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Yuan Tian
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Nakanishi Takeo
(Faculty of Pharmaceutical Sciences, Department of Membrane Transport and Biopharmaceutics, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan)
,
Tajima Hidehiro
(Department of Gastroenterological Surgery, Division of Cancer Medicine, Graduate School of Medical Sciences, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Yamazaki Maiko
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Yokono Rina
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Takabayashi Makiko
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Sawamoto Kazuki
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Akashita Gaku
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Miyamoto Ken-Ichi
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Ohta Tetsuo
(Department of Gastroenterological Surgery, Division of Cancer Medicine, Graduate School of Medical Sciences, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Tamai Ikumi
(Faculty of Pharmaceutical Sciences, Department of Membrane Transport and Biopharmaceutics, Kanazawa University, Kakuma-machi, Kanazawa, 920-1192, Japan)
,
Shimada Tsutomu
(Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan)
,
Shimada Tsutomu
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
,
Sai Yoshimichi
(Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan)
,
Sai Yoshimichi
(Department of Hospital Pharmacy, University Hospital, Kanazawa University, Takara-machi, Kanazawa, 920-8641, Japan)
資料名:
Biopharmaceutics & Drug Disposition
(Biopharmaceutics & Drug Disposition)
巻:
39
号:
5
ページ:
256-264
発行年:
2018年
JST資料番号:
D0863B
ISSN:
0142-2782
CODEN:
BDDID8
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)